financetom
Business
financetom
/
Business
/
ICICI Bank Earnings Preview | NII growth likely to be best in seven years, better NIMs expected
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ICICI Bank Earnings Preview | NII growth likely to be best in seven years, better NIMs expected
Jan 20, 2023 8:43 AM

One of India's largest private lenders, ICICI Bank Ltd. will report results on Saturday, January 21. According to a CNBC-TV18 poll, the bank's projected 27.7 percent growth in its Net Interest Income is likely to be the best in seven years.

The Rs 15,624.3 crore NII number will also mean an improvement of 5.7 percent compared to the September quarter.

ICICI Bank's Net Interest IncomeNII (Rs Crore)Change (YoY, %)
Q3FY23 (Est.)15,624.327.7
Q2FY2314,786.826.5
Q1FY2313,21020.8
Q4FY2212,604.620.8
Q3FY2212,235.923.4

ICICI Bank's bottomline is also likely to grow in excess of 30 percent. However, that would be slower than the growth seen in the previous three quarters.

ICICI Bank's Net ProfitNet Profit (Rs Crore)Change (YoY, %)
Q3FY23 (Est.)8,095.830.7
Q2FY237,557.837.1
Q1FY236,924.950
Q4FY227,018.759.4
Q3FY226,193.725.4

Brokerage firm Philip Capital expects ICICI Bank to report loan growth of 21.1 percent from the same period last year and five percent from the September quarter. Management commentary on loan growth will be keenly awaited.

ICICI Bank's asset quality for the quarter is likely to remain stable. Provisions are expected to decline sequentially due to a decline in stress book. Philip Capital expects slippages to rise marginally to Rs 4,500 crore from Rs 4,366 crore in the September quarter.

ICICI Bank's Asset QualityGross NPA (%)Net NPA (%)
Q3FY23 (Phillip Capital Estimate)3.20.6
Q2FY233.190.61
Q1FY233.410.7
Q4FY223.60.76
Q3FY224.820.99

The movement of the following books will be keenly watched by the street. At Rs 7,683 crore, the watchlist is currently 0.81 percent of total loans. Additionally, at Rs 6,713 crore, the restructured book is 0.72 percent of overall loans.

The bank's Net Interest Margin is also likely to improve on a sequential basis.

Shares of ICICI Bank have been underperformers off late. The stock has corrected close to 10 percent from its 52-week high of Rs 958, which it made on November 30 last year.

Also Read: Private banks poised to report record numbers in third quarter | Earnings Preview

First Published:Jan 20, 2023 5:43 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Shoe Carnival Insider Sold Shares Worth $531,750, According to a Recent SEC Filing
Shoe Carnival Insider Sold Shares Worth $531,750, According to a Recent SEC Filing
Mar 27, 2024
05:21 PM EDT, 03/27/2024 (MT Newswires) -- Carl N. Scibetta, Senior Executive Vice President, Chief Merchandising Officer, on March 26, 2024, sold 15,000 shares in Shoe Carnival ( SCVL ) for $531,750. Following the Form 4 filing with the SEC, Scibetta has control over a total of 108,492 shares of the company, with 108,492 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/895447/000089544724000017/xslF345X03/edgardoc.xml...
Vnet Group Q4 Loss Widens, Revenue Rises; 2024 Revenue Outlook Set
Vnet Group Q4 Loss Widens, Revenue Rises; 2024 Revenue Outlook Set
Mar 27, 2024
05:21 PM EDT, 03/27/2024 (MT Newswires) -- Vnet Group ( VNET ) reported a Q4 loss late Wednesday of 15.88 Chinese renminbi ($2.22) per American depositary share, wider than a loss of 0.42 renminbi a year earlier. One analyst surveyed by Capital IQ expected a loss of 1.29 renminbi. Revenue for the quarter ended Dec. 31 was 1.90 billion renminbi,...
Avalo Therapeutics Shares Triple After Acquisition of AlmataBio, Private Placement Financing of Up to $185 Million
Avalo Therapeutics Shares Triple After Acquisition of AlmataBio, Private Placement Financing of Up to $185 Million
Mar 27, 2024
05:26 PM EDT, 03/27/2024 (MT Newswires) -- Avalo Therapeutics ( AVTX ) shares more than tripled in after-hours trading Wednesday after the company said it acquired closely held AlmataBio and the phase 2-ready anti-IL-1beta mAb, or AVTX-009, to treat hidradenitis suppurativa, a severe autoimmune disease. Concurrently, the company said late Wednesday it entered into a definitive agreement to offer preferred...
Fedex Insider Sold Shares Worth $1,769,904, According to a Recent SEC Filing
Fedex Insider Sold Shares Worth $1,769,904, According to a Recent SEC Filing
Mar 27, 2024
05:21 PM EDT, 03/27/2024 (MT Newswires) -- Susan C Schwab, Director, on March 27, 2024, sold 6,145 shares in Fedex ( FDX ) for $1,769,904. Following the Form 4 filing with the SEC, Schwab has control over a total of 7,865 shares of the company, with 7,865 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1048911/000112760224011311/xslF345X03/form4.xml Price: 287.25, Change: -0.63, Percent Change: -0.22...
Copyright 2023-2026 - www.financetom.com All Rights Reserved